Resources to help promote the consultation
We're keen to get all interested people involved in this consultation.
Here are some resources to help make people aware of the consultation, and encourage them to give feedback.
You're welcome to use these. Let us know if there's anything else that would help us spread the word about this important consultation.
Resources to order or download
You can order printed copies by emailing firstname.lastname@example.org
- Brochure - 2-sided A4 to be folded in half [PDF, 146 KB]
- Poster - A3 colour [PDF, 60 KB]
- Poster - A4 colour [PDF, 59 KB]
Resources for you to use in your communications
- Full consultation document (60-page document) [PDF, 495 KB]
- Email footer banner [PNG, 15 KB]
- Web tile [PNG, 35 KB]
- Presentation about PHARMACs devices consultation [PDF, 1.1 MB]
Consultation on managing fairer access to DHB hospital medical devices
DHBs, PHARMAC, suppliers and others are going to be working together in a new way to deliver fairer access to publicly funded medical devices that are purchased by DHBs for use in hospital or in the community.
“This will involve big changes to the way decisions are made about what devices are funded, and will benefit consumers, DHBs and the wider health system,” says PHARMAC’s Director of Operations, Lisa Williams.
The changes ahead would see PHARMAC take on responsibility for deciding what publicly funded medical devices DHBs can purchase.
The term ‘medical device’ covers diverse products and equipment that are generally used on, in or by a person for a diagnostic or therapeutic purpose.
PHARMAC will be consulting on the new approach from 5 March 2019 to 28 June.
“This is an important consultation, because how we move to the next step will be based on the feedback we get,” says Ms Williams
“We’re committed to working closely with DHBs and others to help us determine the best way to do this.”
“Under the new way of working, each DHB would decide what medical devices they use to deliver their local services, choosing the most appropriate devices from a national medical devices list. PHARMAC would manage this list, including deciding what items get added or removed,” says Ms Williams.
“Our decisions would take into account a range of expert advice, including clinical, technical and operational advice, as well as feedback from public consultation on significant decisions.
“PHARMAC would also manage a process for considering access to items outside the list, when exceptional circumstances require this.”
The new approach is part of ongoing work PHARMAC has been doing to gradually implement the Government’s decision to apply the PHARMAC management model to hospital medical devices.
“The PHARMAC management model is about achieving the best health outcomes possible from within fixed funding,” says Ms Williams.
“We’ve mainly used the model to make medicines funding decisions. The approach to devices is, and will continue to be, specially tailored to account for some unique characteristics of devices. But the model’s principles are just as applicable to devices as they are to medicines.
“These principles include making evidence-based decisions informed by external advice, and using commercial strategies to achieve competitive pricing.”
Applying the PHARMAC management model to DHB hospital medical devices is expected to:
- support more consistent access to medical devices for consumers, regardless of where they live
- help DHBs manage spending on medical devices in a sustainable way
- free up funding, which may be used for new technology or other health initiatives
- ensure there’s a high level of transparency around funding decisions.
“So far, our work in hospital device management has mainly focused on negotiating national contracts for medical devices that DHBs are currently using,” says Ms Williams.
“These contracts are already delivering benefits to DHBs, by enabling them to purchase products on common terms for things like price and supply.
“This work has also helped lay the foundation for the changes coming, by enabling us to steadily build the list of medical devices currently in use, and deepen our understanding of these products.”
When PHARMAC begins managing the national medical devices list, it would largely reflect the products being used by DHBs at that time.
“Over time, we would run commercial processes aimed at achieving better value for money, and this would see changes to the particular brands or products listed,” says Ms Williams.
“However, our focus would always be on ensuring that the list meets DHBs’ requirements as comprehensively as possible, and supports them to maintain or improve clinical outcomes. A range of products would continue to be available in the various different categories of devices, where this is appropriate to meet clinical needs.”
The upcoming consultation will run for four months, and Ms Williams is encouraging anyone with feedback to share it.
“The broad outline of the proposed approach to managing fairer access to hospital medical devices has been shaped by previous sector consultations, engagements, and work with DHBs, so we’ve identified key questions we’re interested in getting feedback on this time,” says Ms Williams.
“It’s really important that the new approach works well and is implemented smoothly, so we want to get as much feedback as possible from anyone involved in using, selecting, managing, supplying or servicing medical devices used or supplied to people by DHBs.”
When and how the new way of working is implemented will depend on the feedback received, with the earliest it could start to take effect likely to be 2020.
For more information go to www.pharmac.govt.nz/devices
Consultation is open until 28 June 2019.
Presentation about PHARMACs devices consultation
Last updated: 10 April 2019